The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:833-834 February 24, 2005 Number 8
NextNext

Preventing Microalbuminuria in Type 2 Diabetes

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Ruggenenti, P.
-PubMed Citation
To the Editor: We applaud the effort by Ruggenenti et al. (Nov. 4 issue)1 to address the issue of primary prevention of microalbuminuria (as a surrogate for early stages of kidney involvement) in patients with hypertension, type 2 diabetes, and normoalbuminuria. Regrettably, they do not provide baseline values for the glomerular filtration rate. From the average baseline data reported, we calculated values for the glomerular filtration rate (using Cockcroft–Gault and modified Modification of Diet in Renal Disease [MDRD] equations2,3) of 63 to 84 ml per minute per 1.73 m2 of body-surface area — values that are low, possibly because . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.